HB Wealth Management’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $334K | Sell |
2,640
-1,088
| -29% | -$138K | ﹤0.01% | 885 |
|
2025
Q1 | $477K | Buy |
3,728
+1,343
| +56% | +$172K | ﹤0.01% | 761 |
|
2024
Q4 | $315K | Sell |
2,385
-150
| -6% | -$19.8K | ﹤0.01% | 785 |
|
2024
Q3 | $369K | Buy |
2,535
+447
| +21% | +$65.1K | ﹤0.01% | 680 |
|
2024
Q2 | $287K | Buy |
2,088
+335
| +19% | +$46K | ﹤0.01% | 719 |
|
2024
Q1 | $241K | Sell |
1,753
-139
| -7% | -$19.1K | ﹤0.01% | 731 |
|
2023
Q4 | $257K | Buy |
1,892
+105
| +6% | +$14.3K | ﹤0.01% | 663 |
|
2023
Q3 | $219K | Buy |
+1,787
| New | +$219K | ﹤0.01% | 676 |
|
2022
Q1 | – | Sell |
-1,749
| Closed | -$267K | – | 598 |
|
2021
Q4 | $267K | Buy |
+1,749
| New | +$267K | 0.01% | 414 |
|